Integratedbio
2 known investors
Find your way into Integratedbio
Integrated Biosciences is a biotech company developing treatments and interventions for aging-related diseases using a combination of medicinal chemistry, biochemistry, aging biology, and artificial intelligence.
Founders & leadership
Investors · 2
Competitors · 5
by search overlapIncyte Corporation15 shared keywordsIncyte is a biopharmaceutical company that develops and commercializes medicines for oncology, hematology, dermatology, and other therapeutic areas. The company focuses on bringing treatments to patients across multiple disease categories.
Intuitive Biosciences14 shared keywordsIntuitive Bio develops Colony Surveillance Assays (CSA), diagnostic kits for screening laboratory animal colonies for exposure to specific pathogens. The kits are designed for research institutions and breeding facilities requiring pathogen-free colony verification.
IQVIA14 shared keywordsIQVIA is a healthcare data and technology company that supports life sciences organizations in research, clinical development, and commercialization of medicines and medical solutions.
Inhibrx12 shared keywordsInhibrx develops protein therapeutics, using target biology and protein engineering to create therapeutic candidates in clinical trials for conditions including sarcoma and head and neck cancer. The company operates in the biotherapeutics and drug development industry.
Life Biosciences11 shared keywordsLongevity company with diversified therapies to extend healthy human lifespan
Companies competing with Integratedbio for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Integratedbio do?
- Integrated Biosciences is a biotech company developing treatments and interventions for aging-related diseases using a combination of medicinal chemistry, biochemistry, aging biology, and artificial intelligence.
- Who are Integratedbio's investors?
- Integratedbio's investors include Sutter Hill Ventures, Page One Ventures.